发布求助
文献互助 智能选刊 最新文献

The open nuclear medicine journal最新文献

筛选
英文 中文
Does the Use of IV Contrast Enhanced CT for Attenuation Correction Affect Clinical Interpretation of Head and Neck PET/CT? 使用静脉增强CT进行衰减校正会影响头颈部PET/CT的临床解释吗?
The open nuclear medicine journal Pub Date : 2011-09-14 DOI: 10.2174/1876388X01103010012
L. Hall, A. Struck, Christopher Guglielmo, C. Jaskowiak, Michael A. Wilson, S. Perlman
{"title":"Does the Use of IV Contrast Enhanced CT for Attenuation Correction Affect Clinical Interpretation of Head and Neck PET/CT?","authors":"L. Hall, A. Struck, Christopher Guglielmo, C. Jaskowiak, Michael A. Wilson, S. Perlman","doi":"10.2174/1876388X01103010012","DOIUrl":"https://doi.org/10.2174/1876388X01103010012","url":null,"abstract":"Purpose of Report: Evaluate the effect of IV contrast use with FDG PET/CT on clinical interpretation of PET images for head and neck cancer. Procedures: 20 consecutive patients referred for PET/CT and contrast enhanced CT of the head and neck had two sets of PET images obtained. One set used standard low dose CT for attenuation correction, and the other used IV contrast enhanced diagnostic quality CT for attenuation correction. Two blinded nuclear medicine physicians interpreted the results. Results: No statistically significant difference in clinical interpretation of the PET images was found. It was noted that PET scans attenuation corrected with IV contrast CTs had greater incidence of abnormal appearing lesions (P<0.01). Conclusion: It is reasonable to use contrast enhanced CT for attenuation correction in PET/CT of head and neck cancer. This would allow for a reduction in radiation dose delivered to patient.","PeriodicalId":88754,"journal":{"name":"The open nuclear medicine journal","volume":"3 1","pages":"12-18"},"PeriodicalIF":0.0,"publicationDate":"2011-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68127782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Human subject with unexpected biodistribution of [11C]PK11195 具有意外生物分布的[11C]PK11195的人类受试者
The open nuclear medicine journal Pub Date : 2011-07-06 DOI: 10.2174/1876388X01103010010
A. Roivainen, K. Någren, J. Virta, J. Rinne
{"title":"Human subject with unexpected biodistribution of [11C]PK11195","authors":"A. Roivainen, K. Någren, J. Virta, J. Rinne","doi":"10.2174/1876388X01103010010","DOIUrl":"https://doi.org/10.2174/1876388X01103010010","url":null,"abstract":"[N-Methyl11 C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinoline carboxamide [ 11 C]PK11195 is a widely used radiopharmaceutical for in vivo assessment of translocator protein 18 kDa (TSPO) activity using positron emission tomography. Here we present an interesting case of unusual distribution of [ 11 C]PK11195, that is a lack of uptake in tissues known for high expression of the TSPO.","PeriodicalId":88754,"journal":{"name":"The open nuclear medicine journal","volume":"3 1","pages":"10-11"},"PeriodicalIF":0.0,"publicationDate":"2011-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68127771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[18F]-FDG PET/CT Scan Detected Giant Cell Arteritis After Negative Temporal Artery Biopsy [18F]-FDG PET/CT扫描发现颞动脉活检阴性巨细胞动脉炎
The open nuclear medicine journal Pub Date : 2011-04-07 DOI: 10.2174/1876388X01103010007
P. Medina-Quiroz, I. Martínez-Rodríguez, I. Banzo, R. Quirce, J. Jiménez-Bonilla, M. D. Arcocha, J. Carril
{"title":"[18F]-FDG PET/CT Scan Detected Giant Cell Arteritis After Negative Temporal Artery Biopsy","authors":"P. Medina-Quiroz, I. Martínez-Rodríguez, I. Banzo, R. Quirce, J. Jiménez-Bonilla, M. D. Arcocha, J. Carril","doi":"10.2174/1876388X01103010007","DOIUrl":"https://doi.org/10.2174/1876388X01103010007","url":null,"abstract":"Giant Cell Arteritis is frequently associated to polymyalgia rheumatica. A 65-years old female patient with a 1- year history of polymyalgia rheumatica was admitted with clinical symptoms and laboratory data of a subacute inflammatory process. Cranial and whole-body CT scans were normal. A (18F)-FDG PET/CT scan showed an extensive increased uptake in the walls of the thoracic and abdominal aorta and also in the common carotid, subclavian and axillary arteries. Biopsy of temporal artery confirmed the diagnosis of giant cell arteritis.","PeriodicalId":88754,"journal":{"name":"The open nuclear medicine journal","volume":"3 1","pages":"7-9"},"PeriodicalIF":0.0,"publicationDate":"2011-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68127710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Detection of Extensive Metastases from Anaplastic Thyroid Cancer by F- 18 FDG-PET/CT F- 18 FDG-PET/CT检测间变性甲状腺癌广泛转移
The open nuclear medicine journal Pub Date : 2011-01-24 DOI: 10.2174/1876388X01103010001
M. Vorster, M. Sathekge
{"title":"Detection of Extensive Metastases from Anaplastic Thyroid Cancer by F- 18 FDG-PET/CT","authors":"M. Vorster, M. Sathekge","doi":"10.2174/1876388X01103010001","DOIUrl":"https://doi.org/10.2174/1876388X01103010001","url":null,"abstract":"Background: Survival with anaplastic thyroid cancer is dependent on how rapid multimodality treatment (chemotherapy, radiotherapy and surgery) and thus accurate assessment of the extent of the disease critical to predict prognosis and therapy planning. Methods & Results: We present a case of anaplastic cancer in a 54-year-old woman who presented with a supra-sternal lump which has decreased in size in response to chemo- and radiotherapy. CT and FDG-PET/CT scan were performed after therapy. CT demonstrated supra-sternal and lung metastases. FDG-PET/CT demonstrated the primary lesion and its distant widespread metastases, beyond the lung and supra-sternal mass. Conclusion: This case emphasizes the need for FDG PET/CT if there is equivocal clinical, laboratory, and radiological evidence of recurrence and metastases, especially if the suspected finding seems can be very unusual for metastatic lesions.","PeriodicalId":88754,"journal":{"name":"The open nuclear medicine journal","volume":"3 1","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2011-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68127694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Radiopharmaceuticals for Molecular Imaging 分子成像用放射性药物
The open nuclear medicine journal Pub Date : 2010-12-14 DOI: 10.2174/1876388X01002010178
Yun-Sang Lee
{"title":"Radiopharmaceuticals for Molecular Imaging","authors":"Yun-Sang Lee","doi":"10.2174/1876388X01002010178","DOIUrl":"https://doi.org/10.2174/1876388X01002010178","url":null,"abstract":"Radiopharmaceuticals for molecular imaging involve careful consideration of the following two factors: radionuclide selection and specificity to the molecular target. In selecting a radionuclide, the specific decay mode, physical half-life, chemical properties, and method of production must be considered. For proper design of a radiopharmaceutical which targets a specific biological or disease process, structural features, including the size, charge, solubility, lipophilicity, and specific activity of the radiolabeled molecules, must be considered. Other factors, such as the rate of metabolism, plasma protein binding, and non-specific binding in non-target tissues, are also important in optimizing the in vivo behavior of radiolabeled molecules. There are several types of radiopharmaceuticals for molecular imaging that target a number of biochemical processes, such as blood flow or perfusion, metabolism, and specific receptors. With a better understanding of the properties of radiopharmaceuticals, including chemical, physical, and biological properties, radiopharmaceuticals can be properly used for molecular imaging of targets for biological or disease processes.","PeriodicalId":88754,"journal":{"name":"The open nuclear medicine journal","volume":"2 1","pages":"178-185"},"PeriodicalIF":0.0,"publicationDate":"2010-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68128021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Molecular Imaging Using Bioluminescence 利用生物发光进行分子成像
The open nuclear medicine journal Pub Date : 2010-12-14 DOI: 10.2174/1876388X01002010157
Byeong‐il Lee, J. Min
{"title":"Molecular Imaging Using Bioluminescence","authors":"Byeong‐il Lee, J. Min","doi":"10.2174/1876388X01002010157","DOIUrl":"https://doi.org/10.2174/1876388X01002010157","url":null,"abstract":"Recent progress in the development of non-invasive imaging technologies continues to strengthen the role of molecular imaging in biological research. Small animal imaging with bioluminescence has been validated recently in a variety of research models and have been shown to provide continuous quantitative monitoring of the location(s), magnitude, and time-variation of gene delivery and/or expression. This article reviews the role of in vivo bioluminescence imaging technologies as they have been used in imaging gene delivery and gene expression for molecular imaging applications. The studies published to date demonstrate that bioluminescence imaging tools will help to understand human diseases through small animal models. disease progression at a molecular pathological level; and (7) To create the possibility of achieving all of the above goals of imaging in a rapid, reproducible, and quantitative manner, so as to be able to monitor time-dependent experimental, developmental, environmental, and therapeutic influences on gene products in the same animal or patient. Diverse optical imaging technologies have been used to investigate molecular events in biology research which is focused on characterizing molecular interaction, signal transduction, enzyme activity, receptor/transporter status and biodistribution of various optical substrates (tracers). The underlying principles of in vitro optical imaging can now be tailored to in vivo optical imaging modalities such as bioluminescence and fluorescence imaging. The development, validation, and application of bioluminescence imaging techniques in living subjects should further enhance our understanding of disease mechanisms and go hand in hand with the development of molecular imaging (1-3).","PeriodicalId":88754,"journal":{"name":"The open nuclear medicine journal","volume":"89 2 1","pages":"157-165"},"PeriodicalIF":0.0,"publicationDate":"2010-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68127889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Preliminary Pre-Clinical Results and Overview on PET/MRI/Fluorescent Molecular Imaging PET/MRI/荧光分子成像的初步临床前结果及综述
The open nuclear medicine journal Pub Date : 2010-12-14 DOI: 10.2174/1876388X01002010153
K. Kang
{"title":"Preliminary Pre-Clinical Results and Overview on PET/MRI/Fluorescent Molecular Imaging","authors":"K. Kang","doi":"10.2174/1876388X01002010153","DOIUrl":"https://doi.org/10.2174/1876388X01002010153","url":null,"abstract":"Molecular imaging is used for earlier detection, characterization of disease and an earlier assessment of treatment efficacy through imaging molecular/cellular events in living organisms. Fluorescent materials, radioisotopes and MRI enhancers as imaging probes, are being used for optical imaging, PET and MRI respectively. Each imaging modality has advantages and limitations regarding sensitivity, resolution, and tissue penetration of signal. Triple modal imaging combining PET/MRI/fluorescent probes will overcome the limitations of each modality. Recent advances in nano- biotechnology have identified many candidate probes for medical applications. Nanoparticles are able to carry fluorescent dyes, radioisotopes, drugs, genes, and targeting biomarkers. Triple modal nanoparticles could apply to sentinel node imaging by combined PET/MRI scanner for surgical plan and then to sentinel node detection by surgeons' view. Furthermore, if targeting function is added to multimodal nanoparticles as molecular probes, they are able to be used for diagnosis in vitro and in vivo, as well as therapeutic purposes. If nanotechnology and molecular imaging is combined, it could guide surgeons for minimal invasive but accurate surgery and physicans for personalized target therapy by validating the targeting efficiency using multimodal in vivo imaging.","PeriodicalId":88754,"journal":{"name":"The open nuclear medicine journal","volume":"20 1","pages":"153-156"},"PeriodicalIF":0.0,"publicationDate":"2010-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68127843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Molecular Imaging Using PET/MRI Particle PET/MRI颗粒分子成像技术
The open nuclear medicine journal Pub Date : 2010-12-14 DOI: 10.2174/1876388X01002010186
D. Hwang, H. Youn, D. S. Lee
{"title":"Molecular Imaging Using PET/MRI Particle","authors":"D. Hwang, H. Youn, D. S. Lee","doi":"10.2174/1876388X01002010186","DOIUrl":"https://doi.org/10.2174/1876388X01002010186","url":null,"abstract":"With the remarkable progress of non-invasive molecular imaging techniques, the nanotechnology could provide powerful tools for development of diagnostic and therapeutic agents in bio-and nano-medicine field. Several imaging techniques including PET and MRI system have been developed for diagnosis, providing functional and anatomical information. Recently, the combined system of PET/MRI imaging modalities with nanoparticles allows the simultaneous monitoring of cancer localization and provides detailed information of nanoparticle distribution in vivo. A variety form of multimodal imaging probes has been developed to overcome the limitation of single imaging modality. In this review, we describe the technological advances associated with nanoparticle-based multimodal imaging system including PET/MRI in living subjects. First, we introduce the simple imaging strategy using optical or PET imaging tracer and the MR imaging approach using a variety of magnetic nanoparticles for the detection of cancer. Then, we cover the improved techniques for efficient targeting with multimodal imaging agents to lymph node area and engrafted cancer sites. In addition, we introduce a successful application of quadruple imaging nanoparticles for the evaluation of more accurate tumor distribution in clinical oncology. These results indicate that multimodal imaging strategy using nanoparticles can endow broad application in multidisciplinary field to monitor a variety of biological systems in a single investigation, and ultimately offer synergistic information for better understanding in diagnosis and therapy of human diseases.","PeriodicalId":88754,"journal":{"name":"The open nuclear medicine journal","volume":"2 1","pages":"186-191"},"PeriodicalIF":0.0,"publicationDate":"2010-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68128121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Multimodal Molecular Imaging In Vivo 体内多模态分子成像
The open nuclear medicine journal Pub Date : 2010-12-14 DOI: 10.2174/1876388X01002010145
J. Paeng, D. Lee
{"title":"Multimodal Molecular Imaging In Vivo","authors":"J. Paeng, D. Lee","doi":"10.2174/1876388X01002010145","DOIUrl":"https://doi.org/10.2174/1876388X01002010145","url":null,"abstract":"In medical research and practice, imaging is now playing a crucial role. With rapidly developing molecular imaging, the role of in vivo imaging is expected to expand much more. In molecular imaging, one of the recent trends is multimodal imaging, which theoretically combines all the strengths of each imaging modality and consequently provides synergism. For this, many multimodal imaging probes have been developed so far. However, multimodal probe imaging is different from simple fusion images using multimodal imaging instruments. To maximize the effectiveness of multimodal in vivo imaging, practical application methods and delicate design of imaging probes are essential. Here, imaging instruments and probes for multimodal in vivo imaging are briefly reviewed and practical application is discussed.","PeriodicalId":88754,"journal":{"name":"The open nuclear medicine journal","volume":"11 1","pages":"145-152"},"PeriodicalIF":0.0,"publicationDate":"2010-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68126450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 35
Technical Advances in Current PET and Hybrid Imaging Systems 当前PET和混合成像系统的技术进展
The open nuclear medicine journal Pub Date : 2010-12-14 DOI: 10.2174/1876388X01002010192
J. Lee
{"title":"Technical Advances in Current PET and Hybrid Imaging Systems","authors":"J. Lee","doi":"10.2174/1876388X01002010192","DOIUrl":"https://doi.org/10.2174/1876388X01002010192","url":null,"abstract":"The continuing efforts of investigators to achieve the best physical and clinical performances from PET (positron emission tomography) and related hybrid cameras (PET/CT and PET/MRI) have led to remarkable technical advances in hardware and software. Time of flight (TOF) information measurement, which has been enabled thanks to the invention of fast, heavy crystals and advances in fast light detection sensors and readout electronics, is used to obtain the PET images of better quality and lesion-detection performance. Statistical reconstruction with resolution recovery and measurements of depth of interaction (DOI) are the useful softwareand hardware-wise approaches for enhancing the spatial resolution of reconstructed PET images. These technical advances along with an expansive increase in the number of PET and PET/CT examinations performed are facilitating the widespread use of PET scanners with specific detector structures and arrangements for particular applications or organs. Combined multimodal imaging systems are also in the development mainstream of these","PeriodicalId":88754,"journal":{"name":"The open nuclear medicine journal","volume":"2 1","pages":"192-208"},"PeriodicalIF":0.0,"publicationDate":"2010-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68127562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信